We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
+16.45%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+648.16%
AUM
$37B
AUM Growth
+$4.8B
Cap. Flow
+$1.03B
Cap. Flow %
2.78%
Top 10 Hldgs %
36.45%
Holding
1,839
New
21
Increased
351
Reduced
1,246
Closed
128

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$380M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$341M
3
NVDA icon
NVIDIA
NVDA
+$253M
4
AMZN icon
Amazon
AMZN
+$245M
5
JPM icon
JPMorgan Chase
JPM
+$236M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$192M
2
DFS
Discover Financial Services
DFS
+$153M
3
CMCSA icon
Comcast
CMCSA
+$140M
4
KO icon
Coca-Cola
KO
+$117M
5
GDDY icon
GoDaddy
GDDY
+$103M

Sector Composition

Rank Sector Weight
1 Technology 35.4%
2 Financials 14.08%
3 Communication Services 12.92%
4 Healthcare 12.04%
5 Consumer Discretionary 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYN icon
1701
Dyne Therapeutics
DYN
$4.89B
$30K ﹤0.01%
3,135
– –
IMVT icon
1702
Immunovant
IMVT
$8.21B
$29K ﹤0.01%
1,807
-1,735
-49% -$26.2K
LUNR icon
1703
Intuitive Machines
LUNR
$2.63B
$26K ﹤0.01%
2,407
– –
HI
1704
DELISTED
Hillenbrand
HI
$25K ﹤0.01%
1,259
-2,141
-63% -$44.5K
NVAX icon
1705
Novavax
NVAX
$1.32B
$22K ﹤0.01%
3,517
-4,437
-56% -$29.4K
SABR icon
1706
Sabre
SABR
$814M
$21K ﹤0.01%
6,516
-13,764
-68% -$35.3K
CDNA icon
1707
CareDx
CDNA
$2.41B
$20K ﹤0.01%
1,034
-2,136
-67% -$38K
ARDX icon
1708
Ardelyx
ARDX
$988M
$19K ﹤0.01%
4,929
-8,777
-64% -$36.2K
VERA icon
1709
Vera Therapeutics
VERA
$2.37B
$17K ﹤0.01%
702
-1,775
-72% -$39.9K
KEX icon
1710
Kirby Corp
KEX
$6.95B
$15K ﹤0.01%
132
-181
-58% -$19K
KMT icon
1711
Kennametal
KMT
$2.52B
$10K ﹤0.01%
425
-2,862
-87% -$59.6K
AAOI icon
1712
Applied Optoelectronics
AAOI
$10.9B
– –
-1,333
Closed -$20K
AAT
1713
American Assets Trust
AAT
$1.4B
– –
-3,217
Closed -$65K
ADNT icon
1714
Adient
ADNT
$1.5B
– –
-5,402
Closed -$69K
ADPT icon
1715
Adaptive Biotechnologies
ADPT
$3.96B
– –
-8,378
Closed -$62K
AGL icon
1716
Agilon Health
AGL
$1.63B
– –
-648
Closed -$70K
AHRT
1717
AH Realty Trust
AHRT
$519M
– –
-4,934
Closed -$37K
AMN icon
1718
AMN Healthcare
AMN
$1.39B
– –
-2,478
Closed -$61K
AMPH icon
1719
Amphastar Pharmaceuticals
AMPH
$921M
– –
-2,159
Closed -$63K
AMWD
1720
DELISTED
American Woodmark
AMWD
– –
-858
Closed -$50K
ANIP icon
1721
ANI Pharmaceuticals
ANIP
$1.77B
– –
-1,273
Closed -$85K
AORT icon
1722
Artivion
AORT
$1.34B
– –
-2,878
Closed -$71K
APOG icon
1723
Apogee Enterprises
APOG
$908M
– –
-1,282
Closed -$59K
ARLO icon
1724
Arlo Technologies
ARLO
$1.66B
– –
-6,167
Closed -$61K
ARVN icon
1725
Arvinas
ARVN
$571M
– –
-2,885
Closed -$20K
67 68
69
70 71

Similar funds

Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
Wealthfront Advisers
Wealthfront Advisers Palo Alto, California $45.6B AUM 18.83% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $47.7B AUM 29.41% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Korea Investment Corp
Korea Investment Corp Seoul, South Korea $48.3B AUM 31.57% 1-Year Est. Return

KBC Group's Q2 2025 Portfolio in Review

As of Q2 2025, KBC Group held 1,839 positions worth $37B, up 15% from $32.2B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

KBC Group's Q2 2025 filing shows 21 new, 351 increased, 1,246 reduced and 128 closed positions. Its largest new stake was Ralliant Corp: 87,075 shares worth $4.22M. The largest sale was IBM, an estimated $192M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Communication Services.

  • KBC Group's largest Q2 2025 buy was Ralliant Corp: 87,075 shares worth $4.22M.
  • KBC Group added most to Microsoft in Q2 2025, an estimated $380M increase.
  • KBC Group's biggest Q2 2025 reduction was IBM, cutting an estimated $192M.
  • KBC Group fully exited Discover Financial Services in Q2 2025, selling an estimated $153M.
  • KBC Group's ten largest holdings make up 36% of its $37B portfolio in Q2 2025.
  • KBC Group opened 21 new positions and closed 128 in Q2 2025.
  • KBC Group's portfolio value rose 15% quarter-over-quarter to $37B.

Based on KBC Group's 13F filing for Q2 2025, filed 8 Aug 2025.